The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension
In patients with cirrhosis and portal hypertension, propranolol use is associated with reduction in BO, increase in intestinal motility and amelioration in intestinal permeability. Moreover IL-6 and LPS levels are being decreased in the majority of patients under propranolol.
Authors
- Spilios Manolakopoulos (ORCID: https://orcid.org/0000-0003-3130-7155)
- George Papatheodoridis (ORCID: https://orcid.org/0000-0002-3518-4060)
- Emilia Hadziyanni
- Nikolaos Papadopoulos (ORCID: https://orcid.org/0000-0002-8702-1685)
- Melanie Deutsch (ORCID: https://orcid.org/0000-0002-3410-8226)
- Elias Xirouchakis (ORCID: https://orcid.org/0009-0008-1700-2295)
- Anastasia Κourikou
- Christos Reppas (ORCID: https://orcid.org/0000-0002-6958-2147)
- Hariklia Kranidioti (ORCID: https://orcid.org/0000-0002-9270-8449)
- Maria Vertzoni (ORCID: https://orcid.org/0000-0003-4463-2459)
Institutions
- National and Kapodistrian University of Athens (GR)
- Laiko General Hospital of Athens (GR)
- Athens Medical Center (GR)
- Hippocration General Hospital (GR)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1186/s12876-024-03483-6
- Citations
- 4
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.48